Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Shattuck Labs Inc STTK

Healthcare Biotechnology
Shattuck Labs, Inc., a biotechnology company, develops antibodies for the treatment of inflammatory and immune-mediated diseases. The company’s lead product candidate includes SL-325, a DR3 blocking monoclonal antibody, which activates immune responses through binding a single receptor, DR3; and SL-425. It also develops multiple preclinical DR3-based bispecific antibodies for the treatment of... see more

Recent & Breaking News (NDAQ:STTK)

Shattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology Symposium

GlobeNewswire 9 days ago

Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire December 15, 2025

Shattuck Labs to Participate in Upcoming December Investor Conferences

GlobeNewswire November 20, 2025

Shattuck Labs Reports Third Quarter 2025 Financial Results and Recent Business Highlights

GlobeNewswire November 6, 2025

Shattuck Labs Announces Participation in Upcoming Wedbush Securities Key Opinion Leader (KOL) and Company Panel

GlobeNewswire October 2, 2025

Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors

GlobeNewswire August 26, 2025

Shattuck Labs Announces IND for SL-325 Is in Effect for the Treatment of Inflammatory Bowel Disease

GlobeNewswire August 21, 2025

Shattuck Labs Reports Second Quarter 2025 Financial Results and Recent Business Highlights

GlobeNewswire August 14, 2025

Shattuck Labs Announces Oversubscribed Private Placement of Up to Approximately $103 Million

GlobeNewswire August 5, 2025

Shattuck Labs Announces Participation in Upcoming Leerink Partners Therapeutics Forum: I&I and Metabolism

GlobeNewswire July 2, 2025

Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights

GlobeNewswire May 1, 2025

Shattuck Labs Announces Participation in Upcoming 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire April 2, 2025

Shattuck Labs Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights

GlobeNewswire March 27, 2025

Shattuck Labs Announces Positive Data from the Preclinical GLP Toxicology Study of SL-325 at the 20th Congress of European Crohn's and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025

GlobeNewswire February 20, 2025

Shattuck Labs Announces Oral Presentation at Upcoming 20th Congress of European Crohn's and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025

GlobeNewswire February 13, 2025

Shattuck Labs Announces Poster Presentation at Upcoming 2025 Crohn's and Colitis Congress

GlobeNewswire February 4, 2025

Shattuck Labs Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 6, 2025

Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2025

GlobeNewswire January 2, 2025

Shattuck Labs Announces Participation in Upcoming December Conferences

GlobeNewswire November 25, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shattuck Labs, Inc. - STTK

ACCESS Newswire November 16, 2024

Podcasts